<DOC>
	<DOC>NCT00435162</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and efficacy of three doses of valsartan (0.25, 1.0, and 4.0 mg/kg) on mean sitting systolic blood pressure (MSSBP) and mean sitting diastolic blood pressure (MSDBP) in 6 months - 5 year old children with hypertension (sitting systolic blood pressure [SSBP] ≥ 95th percentile ).</brief_summary>
	<brief_title>Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>Children aged 6 months 5 years at Visit 1, with a documented history of hypertension Must be able to swallow liquid formulation Must be ≥ 6 kg or ≤ 40 kg at randomization Must have documented history MSSBP (mean of 3 measurements) must be ≥ 95th percentile for age, gender and height, at randomization If patients enter with uncontrolled BP they can remain on background antihypertensives with an unchanged dosing regimen If patients have had a solid organ transplant more than 1 year ago they must be on stable doses of immunosuppressive therapy Parent(s)/guardian(s) are able to follow verbal and/or written instructions in the local language Patients with background ARB therapy Patients demonstrating any clinically significant abnormalities or clinically noteworthy abnormal lab values (other than those relating to renal function) AST/SGOT or ALT/SGPT &gt; 3 times the upper limit of the reference range Glomerular filtration rate &lt; 30 mL/min/1.73m² Serum potassium &gt; upper limit of the reference range MSSBP ≥ 25% above the 95th percentile Patients exhibiting clinically significant ECG abnormalities Patients that have coarctation of the aorta with a gradient of ≥ 30 mm Hg, or renal artery stenosis Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Children</keyword>
	<keyword>pediatrics</keyword>
	<keyword>High Blood Pressure</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Valsartan</keyword>
</DOC>